Insmed Incorporated · 10 hours ago
Manager, Strategic Sourcing Clinical Operations
Headquarters, NJ
Full-time
Hybrid
Mid, Senior Level
$124K/yr - $161K/yr
5+ years expInsmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. The Strategic Sourcing Manager will manage indirect procurement activities within the Clinical Operations category, facilitating sourcing activities for multiple clinical trials and fostering strong supplier partnerships to drive value.
BiotechnologyMedicalPharmaceutical
Responsibilities
Lead RFPs, vendor selection, contract negotiations and onboarding as needed for suppliers related to clinical operations (CROs, IRT, eCOA, laboratory services, etc.)
Drive increased value for the category through sourcing activities, focusing on cost and cash flow improvements and increased supplier performance
Collaborate with the business to manage vendor performance, SLAs and KPIs to ensure alignment with business needs and inform future negotiations
Monitor market trends, compliance requirements and risk factors related to clinical operations
Track and analyze spend to identify initiatives to optimize spending and create greatest supplier value for money
Qualification
Required
A minimum of a Bachelor's degree
5 years of minimum experience within the function
Progressive experience in strategic sourcing, category management, and/or procurement operations is required
Must have strong project management and excellent communication skills (verbal and written), with strong attention to clarity, accuracy, and conciseness
Strong track record of cross-functional collaboration with proven ability to incorporate stakeholder feedback and influence outcomes
Strong business/financial acumen, with proven negotiation skills
High degree of analytical skills, able to synthesize data into meaningful information to support critical business decisions
Must successfully exhibit Insmed's five (5) core corporate competencies of: Collaboration, Accountability, Passion, Respect, and Integrity; along with any other position specific competencies
Must demonstrate the ability to interact successfully in a dynamic and culturally diverse workplace
Preferred
Experience in global sourcing of clinical trials and related services is highly desirable
Experience in pharma/biotech/life sciences and working knowledge of drug development processes is highly desirable
Experience working in a start-up and/or mid-cap sized company highly desired
Benefits
Comprehensive medical, dental, and vision coverage and mental health support, annual wellbeing reimbursement, and access to our Employee Assistance Program (EAP)
Generous paid time off policies, fertility and family-forming benefits, caregiver support, and flexible work schedules with purposeful in-person collaboration
401(k) plan with a competitive company match, annual equity awards, and participation in our Employee Stock Purchase Plan (ESPP), and company-paid life and disability insurance
Company Learning Institute providing access to LinkedIn Learning, skill building workshops, leadership programs, mentorship connections, and networking opportunities
Employee resource groups, service and recognition programs, and meaningful opportunities to connect, volunteer, and give back
Company
Insmed Incorporated
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.
1001-5000 employees
H1B Sponsorship
Insmed Incorporated has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (6)
2023 (14)
2022 (8)
2021 (1)
2020 (5)
Funding
Current Stage
Public CompanyTotal Funding
$4.56BKey Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M
Leadership Team
Drayton Wise
Chief Commercial Officer
Recent News
BioWorld Financial Watch
2025-12-21
Company data provided by crunchbase